Insider Transactions in Q1 2021 at T2 Biosystems, Inc. (TTOO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Michael Terrence Gibbs General Counsel |
SELL
Open market or private sale
|
Direct |
8,758
-10.68%
|
$8,758
$1.56 P/Share
|
|
Mar 24
2021
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+16.89%
|
-
|
|
Mar 17
2021
|
Anthony Pare Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
9,620
-23.33%
|
$9,620
$1.84 P/Share
|
|
Mar 17
2021
|
Alec Barclay Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
12,494
-14.38%
|
$12,494
$1.86 P/Share
|
|
Mar 14
2021
|
Alec Barclay Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,667
+19.95%
|
-
|
|
Mar 14
2021
|
Anthony Pare Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+29.8%
|
-
|
|
Feb 24
2021
|
Alec Barclay Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88,878
-35.89%
|
$0
$0.45 P/Share
|
|
Feb 24
2021
|
Alec Barclay Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
168,488
+40.49%
|
-
|
|
Feb 23
2021
|
Alec Barclay Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,280
-10.04%
|
$14,560
$2.06 P/Share
|
|
Feb 23
2021
|
John M Sprague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,250
-12.89%
|
$10,500
$2.04 P/Share
|
|
Feb 23
2021
|
Michael Terrence Gibbs General Counsel |
SELL
Open market or private sale
|
Direct |
7,280
-10.02%
|
$14,560
$2.06 P/Share
|
|
Feb 21
2021
|
Alec Barclay Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,275
-6.25%
|
$0
$0.47 P/Share
|
|
Feb 21
2021
|
Alec Barclay Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.35%
|
-
|
|
Feb 21
2021
|
John M Sprague Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.71%
|
-
|
|
Feb 21
2021
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.1%
|
-
|
|
Jan 01
2021
|
David B Elsbree |
BUY
Exercise of conversion of derivative security
|
Direct |
34,188
+21.44%
|
-
|
|
Jan 01
2021
|
Seymour Liebman |
BUY
Exercise of conversion of derivative security
|
Direct |
34,188
+28.88%
|
-
|